Is there a connection between low testosterone and dementia, and what does the evidence show in Europe?

Low testosterone and dementia explained: cognitive decline, hypogonadism, observational studies, neuroprotection theories, and clinical interpretation.

In this episode, we review research exploring whether reduced testosterone levels are associated with increased dementia risk and how doctors interpret these findings under EU medical guidance.

You’ll learn:

• What low testosterone (male hypogonadism) is and how it is diagnosed

• How testosterone may influence brain function and neuronal health

• The difference between association and proven causation

• Findings from observational cohort studies

• Why testosterone replacement therapy (TRT) is not prescribed solely to prevent dementia

• The role of cardiovascular health in both ED and cognitive decline

• Situations where TRT requests may be declined without confirmed biochemical deficiency

We explain how doctors assess cognitive symptoms, repeat morning testosterone levels, cardiovascular risk, sleep quality, depression, and medication use during an online consultation in the EU. Current evidence does not establish testosterone therapy as a preventive treatment for dementia.

This episode reflects the clinical standards used by Mobi Doctor, where hormone-related consultations are reviewed by a registered physician in line with EU prescribing guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/low-testosterone-and-dementia-connection-between-low-testosterone-and